BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11317241)

  • 1. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.
    Offidani M; Corvatta L; Olivieri A; Mele A; Brunori M; Montanari M; Rupoli S; Scalari P; Leoni P
    Clin Infect Dis; 2001 May; 32(10):1414-22. PubMed ID: 11317241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
    Bilgrami S; Chakraborty NG; Rodriguez-Pinero F; Khan AM; Feingold JM; Bona RD; Edwards RL; Dorsky D; Clive J; Mukherji B; Tutschka PJ
    Bone Marrow Transplant; 1999 Mar; 23(5):469-74. PubMed ID: 10100561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus infections after autologous bone marrow transplantation in children.
    Wacker P; Hartmann O; Benhamou E; Salloum E; Lemerle J
    Bone Marrow Transplant; 1989 Mar; 4(2):191-4. PubMed ID: 2650789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ; Hart DP; Banerjee L; Ward KN; Peggs KS; Mackinnon S
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.
    Sempere A; Sanz GF; Senent L; de la Rubia J; Jarque I; López F; Arilla MJ; Guinot M; Martín G; Martínez J
    Bone Marrow Transplant; 1992 Dec; 10(6):495-8. PubMed ID: 1362686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.
    Mattiuzzi GN; Cortes JE; Talpaz M; Reuben J; Rios MB; Shan J; Kontoyiannis D; Giles FJ; Raad I; Verstovsek S; Ferrajoli A; Kantarjian HM
    Clin Cancer Res; 2003 Mar; 9(3):976-80. PubMed ID: 12631595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children.
    Takaue Y; Okamoto Y; Kawano Y; Suzue T; Abe T; Saito SI; Sato J; Hirao A; Makimoto A; Kawahito M
    Bone Marrow Transplant; 1994 Aug; 14(2):219-23. PubMed ID: 7994235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS; Miller W; Haake R; Weisdorf D
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH; Kumar D; Messner HA; Minden M; Gupta V; Kuruvilla J; Chae YS; Sohn SK; Lipton JH
    Clin Transplant; 2008; 22(6):770-9. PubMed ID: 18707605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
    N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Varicella-zoster virus infection after hematopoietic stem cell transplantation].
    Akiyama H; Inoue T; Okoshi Y; Mori S; Ohashi K; Maeda Y; Sasaki T; Okuyama Y; Hiruma K; Sakamaki H
    Rinsho Ketsueki; 2000 Jan; 41(1):20-4. PubMed ID: 10695394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
    Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
    Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.